360 NEWS360 NEWS

Business ยท National

Piramal Pharma to acquire remaining 26% stake in Yapan Bio

The drugmaker has exercised a call option, while acquisition consideration and the effective date of share transfer are yet to be finalised

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on โ€œPiramal Pharma to acquire remaining 26% stake in Yapan Bioโ€?

This is self-selected reader participation, not representative scientific polling.